Will The $86m Stelis-Syngene Deal Change India’s Biologics Landscape?

Acquired Plant Seen Operational In 2024

 
• By Vibha Ravi
  
Indian Vaccine Deal
A Handshake To Change India's Biologics Landscape? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip